Meningococcal disease

Alex Koyfman, James Kimo Takayesu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The first cases of meningococcal meningitis were described in Geneva in 1805 and in New England in 1806, the causative agent finally being identified by Anton Weichselbaum in 1887. The first meningococcal epidemics occurred in sub-Saharan Africa in the early 1900s and periodic outbreaks continue to occur worldwide today. Neisseria meningitidis colonizes the naso-oropharyngeal mucosa in approximately 10-20% of healthy individuals. When it invades the bloodstream, meningococcus has the potential to cause devastating disease. It can affect people of any age, but primarily infects children and adolescents. Meningococcemia classically follows an upper respiratory illness consisting of myalgias, fever, headache, and nausea. It can present as an indolent infection with rapid recovery or progress within a few hours into a fulminant illness affecting multiple organ systems. As such, meningococcemia is one of the important causes of sepsis. Prior to antibiotic therapy, the disease carried a 70% mortality rate. Despite advances in early diagnosis and treatment, 10-15% of affected patients die from the disease and another 10-20% are left with severe morbidities (neurologic disability, hearing loss, loss of a limb). Meningococcal disease remains a significant global health threat.

Original languageEnglish (US)
Pages (from-to)174-178
Number of pages5
JournalAfrican Journal for Emergency Medicine
Volume1
Issue number4
DOIs
StatePublished - Dec 2011

Fingerprint

Neisseria meningitidis
meningitis
hearing
disability
Meningococcal Meningitis
morbidity
antibiotics
New England
limb
Africa South of the Sahara
Myalgia
Audition
Hearing Loss
Nausea
Nervous System
Disease Outbreaks
Headache
Early Diagnosis
mortality
Sepsis

Keywords

  • Chemoprophylaxis
  • DIC
  • Meningitis
  • Meningococcemia
  • Meningococcus
  • Sepsis

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Meningococcal disease. / Koyfman, Alex; Takayesu, James Kimo.

In: African Journal for Emergency Medicine, Vol. 1, No. 4, 12.2011, p. 174-178.

Research output: Contribution to journalArticle

Koyfman, Alex ; Takayesu, James Kimo. / Meningococcal disease. In: African Journal for Emergency Medicine. 2011 ; Vol. 1, No. 4. pp. 174-178.
@article{01456fc87a4e44a2a04d1321f32bc341,
title = "Meningococcal disease",
abstract = "The first cases of meningococcal meningitis were described in Geneva in 1805 and in New England in 1806, the causative agent finally being identified by Anton Weichselbaum in 1887. The first meningococcal epidemics occurred in sub-Saharan Africa in the early 1900s and periodic outbreaks continue to occur worldwide today. Neisseria meningitidis colonizes the naso-oropharyngeal mucosa in approximately 10-20{\%} of healthy individuals. When it invades the bloodstream, meningococcus has the potential to cause devastating disease. It can affect people of any age, but primarily infects children and adolescents. Meningococcemia classically follows an upper respiratory illness consisting of myalgias, fever, headache, and nausea. It can present as an indolent infection with rapid recovery or progress within a few hours into a fulminant illness affecting multiple organ systems. As such, meningococcemia is one of the important causes of sepsis. Prior to antibiotic therapy, the disease carried a 70{\%} mortality rate. Despite advances in early diagnosis and treatment, 10-15{\%} of affected patients die from the disease and another 10-20{\%} are left with severe morbidities (neurologic disability, hearing loss, loss of a limb). Meningococcal disease remains a significant global health threat.",
keywords = "Chemoprophylaxis, DIC, Meningitis, Meningococcemia, Meningococcus, Sepsis",
author = "Alex Koyfman and Takayesu, {James Kimo}",
year = "2011",
month = "12",
doi = "10.1016/j.afjem.2011.07.007",
language = "English (US)",
volume = "1",
pages = "174--178",
journal = "African Journal of Emergency Medicine",
issn = "2211-419X",
publisher = "African Federation for Emergency Medicine",
number = "4",

}

TY - JOUR

T1 - Meningococcal disease

AU - Koyfman, Alex

AU - Takayesu, James Kimo

PY - 2011/12

Y1 - 2011/12

N2 - The first cases of meningococcal meningitis were described in Geneva in 1805 and in New England in 1806, the causative agent finally being identified by Anton Weichselbaum in 1887. The first meningococcal epidemics occurred in sub-Saharan Africa in the early 1900s and periodic outbreaks continue to occur worldwide today. Neisseria meningitidis colonizes the naso-oropharyngeal mucosa in approximately 10-20% of healthy individuals. When it invades the bloodstream, meningococcus has the potential to cause devastating disease. It can affect people of any age, but primarily infects children and adolescents. Meningococcemia classically follows an upper respiratory illness consisting of myalgias, fever, headache, and nausea. It can present as an indolent infection with rapid recovery or progress within a few hours into a fulminant illness affecting multiple organ systems. As such, meningococcemia is one of the important causes of sepsis. Prior to antibiotic therapy, the disease carried a 70% mortality rate. Despite advances in early diagnosis and treatment, 10-15% of affected patients die from the disease and another 10-20% are left with severe morbidities (neurologic disability, hearing loss, loss of a limb). Meningococcal disease remains a significant global health threat.

AB - The first cases of meningococcal meningitis were described in Geneva in 1805 and in New England in 1806, the causative agent finally being identified by Anton Weichselbaum in 1887. The first meningococcal epidemics occurred in sub-Saharan Africa in the early 1900s and periodic outbreaks continue to occur worldwide today. Neisseria meningitidis colonizes the naso-oropharyngeal mucosa in approximately 10-20% of healthy individuals. When it invades the bloodstream, meningococcus has the potential to cause devastating disease. It can affect people of any age, but primarily infects children and adolescents. Meningococcemia classically follows an upper respiratory illness consisting of myalgias, fever, headache, and nausea. It can present as an indolent infection with rapid recovery or progress within a few hours into a fulminant illness affecting multiple organ systems. As such, meningococcemia is one of the important causes of sepsis. Prior to antibiotic therapy, the disease carried a 70% mortality rate. Despite advances in early diagnosis and treatment, 10-15% of affected patients die from the disease and another 10-20% are left with severe morbidities (neurologic disability, hearing loss, loss of a limb). Meningococcal disease remains a significant global health threat.

KW - Chemoprophylaxis

KW - DIC

KW - Meningitis

KW - Meningococcemia

KW - Meningococcus

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=84866524907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866524907&partnerID=8YFLogxK

U2 - 10.1016/j.afjem.2011.07.007

DO - 10.1016/j.afjem.2011.07.007

M3 - Article

AN - SCOPUS:84866524907

VL - 1

SP - 174

EP - 178

JO - African Journal of Emergency Medicine

JF - African Journal of Emergency Medicine

SN - 2211-419X

IS - 4

ER -